Swathirajan 2017.
Study characteristics | |||
Patient Sampling | This evaluation study was conducted in specimens collected between July 2015 and June 2016 from HIV‐1 patients attending the Y. R. Gaitonde Centre for AIDS Research and Education (YRG CARE), a tertiary care centre for HIV‐infected individuals in Chennai, Southern India. A total of 103 specimens that were tested by Abbott RealTime PCR as part of patient care services and had remaining samples stored in the freezer at −75 ± 5 °C, were utilized for this validation anonymously without using patient identifiers. | ||
Patient characteristics and setting | HIV‐1 patients from a tertiary care centre for HIV‐infected individuals in Chennai, Southern India. | ||
Index tests | Xpert HIV‐1 Viral Load assay on frozen plasma specimens done in a laboratory. | ||
Target condition and reference standard(s) | High viral load > 1000 copies/mL; Abbott RealTime PCR. | ||
Flow and timing | Both assays were performed as per the manufacturers’ instructions. A total of 103 specimens that were tested by Abbott RealTime PCR as part of patient care services and had remaining samples stored in the freezer at −75 ± 5 °C, were utilized for this validation anonymously without using patient identifiers. It was ensured that all the specimens were subjected to a single freeze–thaw cycle prior to testing using the Xpert HIV‐1 Viral Load assay. | ||
Comparative | |||
Notes | |||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | Unclear | ||
Could the selection of patients have introduced bias? | Unclear risk | ||
Are there concerns that the included patients and setting do not match the review question? | Unclear | ||
DOMAIN 2: Index Test (All tests) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Could the conduct or interpretation of the index test have introduced bias? | Unclear risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | High | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | Unclear risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | Low concern | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Yes | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Could the patient flow have introduced bias? | Low risk |
Abbreviations: ART: antiretroviral therapy; DBS: dried blood spots; EDTA: ethylenediaminetetraacetic acid; PCR: polymerase chain reaction; POC VL: point‐of‐care viral load; RNA: ribonucleic acid; SAMBA: simple amplification‐based assay; Semi‐Q: semi‐quantitative.